Abstract CT160: The integration of PD1 blockade with epigenetic therapy is highly active and safe in heavily treated patients with T-cell lymphomaEnrica Marchi, Owen A. O’Connor, Jennifer Kimberly Lue et al.|Cancer Research|2020Cited by 4
P1142: AFM13 IN PATIENTS WITH R/R PERIPHERAL T CELL LYMPHOMA (PTCL): A POST-HOC SUBGROUP ANALYSIS FROM THE REDIRECT STUDYWon-Seog Kim, Steven M. Horwitz, Jake Shortt et al.|HemaSphere|2023Cited by 4